Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China
· Delayed Price · Currency is CNY 40.90
-1.22 (-2.90%)
At close: Mar 9, 2026
Lifecome Biochemistry Revenue
Lifecome Biochemistry had revenue of 115.80M CNY in the quarter ending September 30, 2025, a decrease of -20.45%. This brings the company's revenue in the last twelve months to 587.04M, up 0.98% year-over-year. In the year 2024, Lifecome Biochemistry had annual revenue of 649.37M with 28.08% growth.
Revenue (ttm)
587.04M
Revenue Growth
+0.98%
P/S Ratio
10.83
Revenue / Employee
653.72K
Employees
898
Market Cap
6.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
| Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
| Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
| Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
| Dec 31, 2020 | 308.15M | 4.39M | 1.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai OPM Biosciences | 354.91M |
| Beijing Konruns Pharmaceutical | 871.31M |
| Xiangxue Pharmaceutical | 1.47B |
| GemPharmatech | 793.25M |
| R&G PharmaStudies | 789.45M |
| Shenzhen Weiguang Biological Products | 1.14B |
| Jiangsu Aidea Pharmaceutical Group | 720.67M |
| Kexing Biopharm | 1.54B |